CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3030% below fair value
$89.35−0.44 (-0.49%)
Close on Nov 13, 2026Market cap $114.28BP/E 10.4Yield 2.98%
Cvs Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cvs Health's operating cash flow for the twelve months ending Sep 30, 2026 was $18.71B, up 105.4% year over year. For fiscal 2025 it was $10.64B, up 16.8% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $18.27B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.64B | +16.8% |
| FY2024 | Dec 31, 2024 | $9.11B | -32.2% |
| FY2023 | Dec 31, 2023 | $13.43B | -17.0% |
| FY2022 | Dec 31, 2022 | $16.18B | -11.4% |
| FY2021 | Dec 31, 2021 | $18.27B | +15.1% |
| FY2020 | Dec 31, 2020 | $15.87B | +23.5% |
| FY2019 | Dec 31, 2019 | $12.85B | +44.9% |
| FY2018 | Dec 31, 2018 | $8.87B | +10.7% |
| FY2017 | Dec 31, 2017 | $8.01B | -21.0% |
| FY2016 | Dec 31, 2016 | $10.14B | +18.8% |
| FY2015 | Dec 31, 2015 | $8.54B | +4.9% |
| FY2014 | Dec 31, 2014 | $8.14B | +40.7% |
| FY2013 | Dec 31, 2013 | $5.78B | -13.3% |
| FY2012 | Dec 31, 2012 | $6.67B | +13.9% |
| FY2011 | Dec 31, 2011 | $5.86B | +22.5% |
| FY2010 | Dec 31, 2010 | $4.78B | +18.4% |
| FY2009 | Dec 31, 2009 | $4.04B | +2.2% |
| FY2008 | Dec 31, 2008 | $3.95B | +22.2% |
| FY2007 | Dec 29, 2007 | $3.23B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.72B | +493.5% |
| Q2 FY2026 | Jun 30, 2026 | $6.35B | +234.5% |
| Q1 FY2026 | Mar 31, 2026 | $4.25B | -6.7% |
| Q4 FY2025 | Dec 31, 2025 | $3.39B | +82.3% |
| Q3 FY2025 | Sep 30, 2025 | $796.00M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.90B | -38.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.56B | -7.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.86B | – |
| Q3 FY2024 | Sep 30, 2024 | -$745.00M | -127.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.09B | -47.7% |
| Q1 FY2024 | Mar 31, 2024 | $4.90B | -34.1% |
| Q4 FY2023 | Dec 31, 2023 | -$2.64B | – |
| Q3 FY2023 | Sep 30, 2023 | $2.72B | -70.2% |
| Q2 FY2023 | Jun 30, 2023 | $5.91B | +8.5% |
| Q1 FY2023 | Mar 31, 2023 | $7.44B | +108.8% |
| Q4 FY2022 | Dec 31, 2022 | -$1.95B | -148.7% |
| Q3 FY2022 | Sep 30, 2022 | $9.12B | +65.2% |
| Q2 FY2022 | Jun 30, 2022 | $5.44B | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.56B | +23.2% |
| Q4 FY2021 | Dec 31, 2021 | $4.01B | +12.3% |
| Q3 FY2021 | Sep 30, 2021 | $5.52B | +194.6% |
| Q2 FY2021 | Jun 30, 2021 | $5.85B | -17.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.89B | -12.5% |
| Q4 FY2020 | Dec 31, 2020 | $3.57B | +35.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.87B | -36.0% |
| Q2 FY2020 | Jun 30, 2020 | $7.12B | +33.4% |
| Q1 FY2020 | Mar 31, 2020 | $3.31B | +69.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.63B | +6.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.93B | +166.9% |
| Q2 FY2019 | Jun 30, 2019 | $5.34B | +81.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.95B | -17.3% |
| Q4 FY2018 | Dec 31, 2018 | $2.48B | – |
| Q3 FY2018 | Sep 30, 2018 | $1.10B | -58.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.93B | +46.8% |
| Q1 FY2018 | Mar 31, 2018 | $2.36B | -33.3% |
| Q4 FY2017 | Dec 31, 2017 | -$136.00M | -106.4% |
| Q3 FY2017 | Sep 30, 2017 | $2.61B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.00B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.53B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.12B | – |
See a number that looks wrong?